Galapagos NV
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
GLPG | BR
Overview
Corporate Details
- ISIN(s):
- BE0003818359
- LEI:
- 549300QKJ78IY0IOV655
- Country:
- Belgium
- Address:
- Industriepark Mechelen Noord, Generaal De Wittelaan L11 A3, 2800 Mechelen
- Website:
- https://www.glpg.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Galapagos NV is a biotechnology company dedicated to transforming patient outcomes through scientific innovation. Following a strategic restructuring, the company now focuses on developing and commercializing novel cell therapies, particularly in oncology. It leverages a unique, decentralized, and scalable manufacturing platform designed to rapidly deliver CAR-T therapies to patients. Galapagos is actively growing its pipeline through strategic acquisitions and partnerships while seeking to divest its legacy small molecule assets. The company's mission is to develop life-changing treatments to provide patients with more years of life and improved quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-26 07:30 |
Investor Presentation
GALAPAGOS_NV_Corp_Structure_TD_14.11.2025.pdf
|
German | 151.3 KB | ||
| 2025-11-26 07:30 |
Investor Presentation
GALAPAGOS_NV_Corp_Structure_TD_12.11.2025.pdf
|
German | 151.9 KB | ||
| 2025-11-26 07:30 |
Major Shareholding Notification
GALAPAGOS NV Form TD 14.11.2025_Revised Part I.pdf
|
English | 956.3 KB | ||
| 2025-11-26 07:30 |
Major Shareholding Notification
GALAPAGOS NV Form TD 12.11.2025_Part I_Revision2.pdf
|
English | 956.0 KB | ||
| 2025-11-26 07:30 |
Major Shareholding Notification
Galapagos Receives Transparency Notifications from Bank of America .pdf
|
English | 243.9 KB | ||
| 2025-11-26 07:30 |
Major Shareholding Notification
Galapagos ontvangt transparantieverklaringen van Bank of America .pdf
|
Dutch | 283.4 KB | ||
| 2025-11-05 22:01 |
Earnings Release
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Upda…
|
English | 465.4 KB | ||
| 2025-11-05 22:01 |
Earnings Release
Galapagos rapporteert financiële resultaten over de eerste negen maanden van 20…
|
Dutch | 593.4 KB | ||
| 2025-10-21 07:30 |
Regulatory Filings
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the…
|
English | 274.0 KB | ||
| 2025-10-21 07:30 |
Regulatory Filings
Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onde…
|
Dutch | 288.2 KB | ||
| 2025-08-08 07:36 |
Share Issue/Capital Change
Galapagos Creates New Subscription Right Plan
|
Dutch | 203.1 KB | ||
| 2025-08-08 07:36 |
Share Issue/Capital Change
Galapagos Creates New Subscription Right Plan
|
English | 201.6 KB | ||
| 2025-08-07 00:00 |
Remuneration Information
Galapagos_PR_07082025_ENG.pdf
|
English | 208.3 KB | ||
| 2025-08-07 00:00 |
Remuneration Information
Galapagos_PR_07082025_NL.pdf
|
Dutch | 215.6 KB | ||
| 2025-08-07 00:00 |
Report Publication Announcement
1. Subscription Right Plan 2025 (B)_Board Report_7_180-7_191_ENG_FINAL_Website(…
|
English | 262.4 KB |
Automate Your Workflow. Get a real-time feed of all Galapagos NV filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Galapagos NV
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Galapagos NV via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-14 | EcoR1 Capital Fund Qualified, L.P. | Close relation | Buy | 74,882 | 1,982,155.75 USD |
| 2025-05-14 | EcoR1 Capital Fund, L.P. | Close relation | Buy | 5,001 | 132,378.39 USD |
| 2025-05-13 | EcoR1 Capital Fund Qualified, L.P. | Close relation | Buy | 212,513 | 4,893,600.61 EUR |
| 2025-05-13 | EcoR1 Capital Fund Qualified, L.P. | Close relation | Buy | 150,773 | 3,974,693.32 USD |
| 2025-05-13 | EcoR1 Capital Fund, L.P. | Close relation | Buy | 14,192 | 326,803.44 EUR |
| 2025-05-13 | EcoR1 Capital Fund, L.P. | Close relation | Buy | 10,068 | 265,413.40 USD |
| 2025-05-01 | Huston Thad | Board | Other | 32,645 | 724,066.10 EUR |
| 2025-05-01 | Cnossen Valeria | Board | Other | 19,836 | 439,962.48 EUR |
| 2025-05-01 | Missotten Annelies | Board | Other | 16,577 | 367,677.86 EUR |
| 2025-01-10 | Contamine Jérôme | Board | Buy | 1,158 | 30,800.87 EUR |
Peer Companies
